CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 44 enrolled
Drug / intervention
Alpha-Stim Active +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03369418
NCT03369418N/ACompleted
CompareCT.gov

The Effect of Cranial Electrotherapy Stimulation on Emotional and Cellular Wellbeing

University of California, Los Angeles·interventional·Posted Dec 12, 2017·Updated Aug 19, 2020

In Brief

A clinical study evaluating Alpha-Stim Active and Alpha-Stim Inactive for Anxiety and Depression. Completed, enrolled 44 participants across 1 site.

Detailed Summary

The investigators aim to use a CES (cranial electrotherapy stimulation) intervention to improve emotional well-being by reducing symptoms of anxiety and depression and to assess for changes in markers of cellular health - specifically, telomere length and telomerase activity

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnxiety, Depression
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedDec 12, 2017
Enrollment StartMar 1, 2016
Primary CompletionOct 20, 2018
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 8.6 years ago

Interventions

Alpha-Stim Activedevice

The study device is a safe, commercially available take-home cranial electrotherapy stimulation device that applies an electrical current to a subject's head to treat anxiety, depression or insomnia

Alpha-Stim Inactivedevice

The study device given to the inactive group will be identical to the active except the electrodes attached to the device will be inactive. The device will not transmit anything when turned on because the electrodes are inactive.